ArticleEJNMMI physics2025
Machine-learning based quantification of lung shunt fraction from 99mTc-MAA SPECT/CT for selective internal radiation therapy of liver tumors using TriDFusion (3DF).
Article in EJNMMI physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF).EJNMMI research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPrior to selective internal radiotherapy of liver tumors, a determination of the lung shunt fraction (LSF) is performed using 99mTc- macroaggregated albumin (99mTc-MAA) injected into the hepatic artery. Most commonly planar but sometimes SPECT/CT images are acquired upon which regions of interests are drawn manually to define the liver and the lung. The LSF is then calculated by taking the count ratios between these two organs. An accurate estimation of the LSF is necessary to avoid an excessive pulmonary irradiation dose.
methodsIn this study, we propose a computational, semi-automatic approach for LSF calculation from SPECT/CT scans, based on machine learning 3D segmentation, implemented within TriDFusion (3DF). We retrospectively compared this approach with the LSF calculated using the standard planar approach on 150 patients. Using CT images (from the SPECT/CT) as a blueprint, the TotalSegmentor machine learning algorithm automatically computes masks for the liver and lungs. Then, the SPECT attenuation-corrected images are fused with the CT and, based on the CT segmentation mask, TriDFusion (3DF) generates volume-of- interest (VOI) regions on the SPECT images. The liver and lung VOIs are further augmented to compensate for breathing motion. Finally, the LSF is calculated using the number of counts in the respective VOIs. Measurements using an anthropomorphic 3D-printed phantom with variable 99mTc activity concentrations for the liver and lungs were performed to validate the accuracy of the algorithm.
resultsOn average, LSF determined from 2D planar images were between 21 and 70% higher than those determined from SPECT/CT data. Semi-automated determination of the LSF using TriDFusion (3DF) analysis of SPECT-CT acquisitions was within 4-12% of the phantom-determined ratio measurements (ground truth).
conclusionsThe utilization of TriDFusion (3DF) AI 3D Lung Shunt is a precise method for quantifying lung shunt fraction (LSF) and is more accurate than planar 2D image-based estimates. By incorporating machine learning segmentation and compensating for breathing motion, the approach underscores the potential of artificial intelligence (AI)-driven techniques to revolutionize pulmonary imaging, providing clinicians with efficient and reliable tools for treatment planning and patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.